BACK TO ALL STUDIES

Fort Bragg, NC: Joint Special Operations Command (JSOC) Seroepidemiological Study

PRIMARY OBJECTIVE(s)

To determine force readiness through the use of serological and RNA assays for SARS-CoV-2.

PRINCIPAL INVESTIGATOR(S)

Sammy Choi

CONTACT
Sammy Choi
young.s.choi.civ@mail.mil
TREATMENT/CLINICAL & LAB INVESTIGATION

No treatment. SARS-CoV-2 viral and antibody testing.

POPULATION
Fort Bragg Active duty Soldiers who are part of JSOC and theif family members
FULL NAME OF DIAGNOSTIC TEST

Biofire® Fim Array® Respiratory (RP2plus) Panels, FimArray Bio-agent system (Biofire, Diagnostics, Salt Lake City, Utah)

Lab Used for Diagnostic Test
Womack Army Medical Center, BSL-3 Laboratory, Fort Bragg, NC
Full Name of Serology/Antibody Test

Roche Elecsys Anti-SARS-CoV-2 assay on the Roche Cobas e System of IgG and IgM

Lab Used for Serology/Antibody Test
Womack Army Medical Center, Fort Bragg, NC
Want more information about this study?
study website